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Breast cancer is the most common malignancy in women worldwide, and dietary lipids are important environmental factors influencing its etiology. We have
investigated the effects, and the mechanisms associated, of high-fat diets on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Animals were fed a
low-fat, a high-corn-oil (HCO) or a high-extra-virgin-olive-oil (HOO) diet from weaning or after induction. The HCO diet had a clear stimulating effect on
mammary carcinogenesis, especially when dietary intervention started after induction, whereas the tumors from HOO diet groups exhibited clinical and
morphological characteristics similar to those from low-fat controls. Transcriptomic and further protein and immunohistochemical analyses of tumors also
indicated different modulatory effects of high-fat diets affecting relevant biological functions: metabolism, immunosurveillance and proliferation/apoptosis
pathways. Thus, the results suggested different metabolic adaptations with increased glycolysis by effect of HOO diet. Moreover, leukocyte tumor infiltration and
inflammation mediators showed increased cytotoxic T cells and decreased TGFβ1 expression by the HOO diet, while the HCO one increased arginase expression
and IL-1α plasma levels. Furthermore, the study of proteins controlling proliferation/apoptosis pathways (Sema3A, Stat5, Smad1, Casp3) suggested an increase
in proliferation by the HCO diet and an increase of apoptosis by the diet rich in olive oil. In conclusion, the HCO diet clearly stimulated mammary carcinogenesis,
especially in the promotion phase, and induced molecular changes suggesting increased tumor proliferation/apoptosis balance and a proinflammatory
microenvironment. The HOO diet, despite being high fat, had a weaker effect on tumorigenesis probably related to metabolic adaptations, enhanced
immunosurveillance and increased apoptosis.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Dietary lipids; Breast cancer; Olive oil; Transcriptome; Immune system; Apoptosis; Metabolism1. Introduction
Breast cancer was the most common cancer overall in 2015, with
2.4 million cases worldwide, and a leading cause of women death [1].
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virgin olive oil; LF, low fat; MUFA, monounsaturated fatty acids; PUFA, polyunsatur
☆ Funding: This work was supported by grants from “Plan Nacional de I+D+
(FPCO2008-165.396; FPCO2013-CF611.084); “Agencia para el Aceite de Oliva delMin
“Organización Interprofesional del Aceite de Oliva Español (OIAOE)” (OIP2009-CD16
Generalitat de Catalunya” (GC2010-165.000), FPCO and OIAOE (FPCO-OIP2016-CF6
☆☆ Author disclosures: no conflicts of interest.
⁎ Corresponding authors at: Department of Cell Biology, Physiology and Immu
Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Barce
E-mail addresses: m.fmm@uab.cat (R. Escrich), icosta@tauli.cat (I. Costa), gr.mec
(E. Vela), Eduard.Escrich@uab.cat (E. Escrich), Raquel.Moral@uab.cat (R. Moral).
https://doi.org/10.1016/j.jnutbio.2018.11.001
0955-2863/© 2018 The Authors. Published by Elsevier Inc. This is an open access article undenvironmental factors, diet being one of the most important [2].
Although there are some controversial data, epidemiological and
especially experimental data have shown the effects of dietary lipids
on breast cancer risk [2–5]. Thus, their influence on malignant
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mental data have revealed that, in general, n-6 polyunsaturated fatty
acids (PUFA) and animal saturated fatty acids clearly promote breast
cancer, whereas n-3 PUFAwould inhibit tumor growth andmetastasis
[3,4]. In relation to monounsaturated fatty acids (MUFA), evidence is
still inconclusive, with data ranging from protective to weak
promoting effects on experimental breast carcinogenesis [3,4].
Epidemiological data indicate that women in the Mediterranean
European countries have lower rates of breast cancer than in other
Western countries [5,6]. Mediterranean diet is characterized by the
consumption of olive oil (rich in the MUFA oleic acid) as the main
source of fat [7].
Although there is increasing experimental evidence of the
influence of diet on the development of neoplastic diseases, fewer
data support that dietary factors may influence not only the clinical
manifestation of the disease but also the histopathologic degree of
malignancy, which has important prognostic value [8]. Moreover, the
molecular mechanisms by which dietary lipids may influence
mammary gland transformation are not well elucidated, but modifi-
cations in hormonal status, structure and function of cell membranes,
signaling pathways or gene expression have been reported [3,4]. It has
long been known that dietary lipids can modulate the expression of
metabolism genes in tissues like liver, but scarce evidence exists on
their effects on cancer-related genes [9]. We have previously
demonstrated that the stimulating effect of a corn-oil-enriched diet
on experimentalmammary carcinogenesis can bemediated, at least in
part, by transcriptomic changes affecting the expression of differen-
tiation genes [10]. In this work, we aimed to investigate the effects of
different high-fat diets, i.e., high in a seed oil (rich in n-6 PUFA) or in
extra-virgin olive oil (EVOO, rich in oleic acid and bioactive
compounds) and administered from prepuberty or in adulthood, on
clinical and anatomopathological characteristics of experimental
mammary tumors. Moreover, to gain insight into the molecular
mechanisms underlying such effects, we investigated transcriptomic
changes in tumors suggesting changes inmetabolism, immune system
function and proliferation/apoptosis pathways.
2. Methods
2.1. Diets
Three semisynthetic diets were designed: a low-fat diet (LF, 3%
corn oil w/w), a high-corn-oil-diet (HCO, 20% corn oil) and a high-
olive-oil-diet (HOO, 3% corn oil+17%EVOO) (Supplementary Table 1).
Carbohydrates in the form of dextrosewere 67.9%w/w in LF and 45.9%
in the high-fat diets. They also contained protein in the form of casein
(18% w/w in LF diet and 23% in the high-fat diets) and 5% w/w
cellulose, 5.9% w/w salt mixture and 0.24% w/w vitamin mixture. In
order to maintain the normal lipidic metabolism, they were
supplemented with methionine (0.51% w/w in LF and 0.66% in the
high-fat diets), choline (1800 mg/kg diet) and folic acid (5 mg/kg
diet). The definition, preparation and suitability of the experimental
diets were previously described [11–13], as well as the specific
composition of the oils used [14]. Diets were prepared weekly and
stored under nitrogen in the dark at 4°C.
2.2. Animals and experimental design
All animals received humane care under an institutionally
approved experimental animal protocol, following the legislation
applicable in Spain. Female Sprague–Dawley Crl:SD rats were
purchased from Charles River Lab (L'Arbresle Cedex, France) at 23
days of age and maintained under standard conditions. Animals were
distributed according to the type and timing of dietary intervention,
thus diets influencing initiation and promotion, or only promotion ofthe carcinogenesis. From weaning, animals were fed a low-fat diet
(group LF, n=60), a high-corn-oil diet (group HCO, n=20) or a high-
extra-virgin-olive-oil diet (group HOO, n=20) (Fig. 1). At 53 days of
age, mammary tumorswere induced by oral gavagewith a single dose
of 5 mg of 7,12-dimethylbenz(a)anthracene (DMBA) (Sigma-Aldrich,
St. Louis, MO, USA) dissolved in corn oil. After induction, 40 rats from
LF group were changed to high-fat diets (groups LF-HCO and LF-HOO,
n=20 each). Body weights were measured weekly throughout the
assay, and nose-to-anus length was measured at days 36, 51, 100 and
the end of the assay to calculate body mass index (g/cm2). On days
236–256, rats were euthanized by decapitation. Plasma was obtained
and maintained at −80°C until used. Tumors were removed and
measured, a portion of each was fixed in 4% buffered formalin, and the
rest was flash-frozen and stored at−80°C. Only confirmed mammary
adenocarcinomas have been included in this study.
2.3. Characterization of tumor malignant phenotype and tumor growth
Tumor phenotype was characterized determining the degree of
morphological aggressiveness by applying the modified Scarff–Bloom–
Richardson grading method adapted to rat mammary adenocarcinomas
that we previously described [15]. This global histopathologic grade of
adenocarcinomas adds together the differentiation pattern, nuclear
pleomorphism and mitotic index and scores 3–5 points (grade I or well
differentiated), 6–8 points (grade II or moderately differentiated) and 9–
11 points (grade III or poorly differentiated). Moreover, though most rat
mammarycarcinomasareknown tobenodular andvery clearlybounded,
stromal response to the invasion was classified as absent (−) or as
positive (+) when occasional prominent fibroblasts were seen around
neoplastic nests. Significant cellular and stromal reactionwas classified as
++or+++depending on the extent and intensity of the response, the
latterwhen a truly desmoplastic reactionwas present.Microscopic tumor
necrosis was also evaluated as absent, focal or extensive.
On the other hand, tumor growth was characterized with several
carcinogenesis parameters: latency (average time from carcinogen
administration to first palpable malignant tumor), tumor incidence
(percentage of rats bearing at least one tumor), tumor yield
(cumulative total number of tumors) and total tumor volume (volume
of all the tumors of the group).
2.4. RNA extraction and microarrays analysis
Total RNA was isolated using the RNeasy Mini Kit (QiaGen, Hilden,
Germany) according to the manufacturer. RNA quality was analyzed
by Agilent Bioanalyzer 2100 and by ethidium-bromide-stained
agarose gel electrophoresis.
Six mammary adenocarcinomas of each group were chosen for
whole-genome gene expression profiling. Briefly, GeneChip Rat Exon
1.0 ST Array filters containing probesets for 850,000 exons were
obtained from Affymetrix (Santa Clara, CA, USA). Threemicrograms of
RNA (integrity number N8) was labeled with One-Cycle Target
Labeling and Control Reagent (Affymetrix), hybridized to chips
(Hybridization oven 640, Affymetrix) and scanned using GeneChip
Scanner 3000 7G (Affymetrix) in the Microarrays Service from Vall
d'Hebron Research Institute.
Images obtained were processed with Microarray Analysis Suite
5.0 (Affymetrix). Raw expression values were preprocessed using the
RMA method [16]. Data were also nonspecific filtered to remove low-
signal and low-variability genes. These normalized and filtered values
were the basis for all the analysis. Microarray data have been
deposited at ArrayExpress under accession number E-MTAB-3541.
The selection of differentially expressed genes between conditions
was based on a linear model analysis [17]. Different statistics tests
(fold change, t or P values) were used to classify genes into ranks
depending on its differential expression. In order to deal with the
Fig. 1. Experimental design. Female Sprague–Dawley rats were fed the low-fat control diet (LF), the high-corn-oil diet from weaning (HCO) or from induction (LF-HCO), and the high-
EVOO diet from weaning (HOO) or from induction (LF-HOO); n=20 animals/group. Animals were induced with 5 mg of DMBA at 53 days of age and euthanized at 236–256 days.
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over the false discovery rate using the Benjamini and Hochberg
method [18].
We performed analysis of biological significance based on
overrepresentation tests aiming to establish if genes found as
differentially expressed were concentrated in some Gene Ontology
(GO) categories. Enrichment tests were performed using PANTHER
(Protein ANalysis THrough Evolutionary Relationships) Classification
System and Genecodis and FatiGO from Babelomics tool, where
Fisher's Exact Test for 2×2 contingency tables and multiple test
correction were applied to find significant overrepresentation of GO
terms.
2.5. Reverse transcription and real-time PCR
Two micrograms of total RNA was reverse-transcribed using the
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems;
Foster City, CA, USA). Twenty-five nanograms of cDNA was amplified
by real-time PCR with TaqMan methodology in the iCycler iQ Real-
Time PCR detection system (Bio-Rad Laboratories, Hercules, CA, USA).
Specific Gene TaqMan Assays for Scd, Fabp3, Notch4, Pfkl, Il18, Il2Rg,
Sema3a, Jak2, Smad1, Stat5a, Cdkn2b, Arg1, Nos2, TGFβ1 and Hprt as
the housekeeping control gene were obtained from Applied Biosys-
tems. PCRs were performed at 10 min at 95°C followed by 15 s at 95°C
and 60 s at 60°C for 40 cycles. Cycle thresholds (Ct) for each sample
were obtained and 2−ΔCt calculated.
2.6. Protein extraction and Western blot
Tumor samples were homogenized in a buffer containing 50 mM
Tris–HCl pH 7.2, 250 mM sucrose, 2 mM EDTA, 1 mM EGTA, 5 mM
MgCl2, 50 μMNaF, 100 μMNa3VO4, 10 μl/ml protease inhibitor cocktail
(Sigma-Aldrich), 10 mM β-mercaptoethanol and 1% Triton X-100.
Protein extracts (10–20 μg) were subjected to SDS-PAGE on a 7.5%
acrylamide using the Mini-Protean TGX Stain Free Gels and trans-
ferred to PVDF membrane with Trans-Blot Turbo Transfer Sytstem
(Bio-Rad). Primary antibodies and dilutions used were anti-GLUT1
(Cell Signaling Technology, 1:1000), anti-PFKL (Cell Signaling Tech-
nology, 1:500), anti-ALDOA (Cell Signaling Technology, 1:1000), anti-
NOTCH4 (Abcam, Cambridge, 1:5000), anti-Semaphorin 3A (Abcam,
1:3000), anti-SMAD 1/5/9 (Abcam, 1:1000), anti-Phospho-SMAD 1/5/
9 (Cell Signaling Technology, 1:500), anti-STAT5A/B (Cell Signaling
Technology) (1:3000), anti-CASP3 (Cell Signaling Technology,1:2000) and anti-PCNA (Cell Signaling Technology, 1:5000). After
incubation with secondary antibody (Sigma-Aldrich) and Luminata
Forte Western HRP Substrate (EMD Millipore) luminogen, proteins
were visualized using the Chemidoc XRS+ hardware associated with
Image Lab Software 5.1-Beta (Bio-Rad). This Bio-Rad system normal-
izes the densitometric values of the bands with the total protein
loaded in each line, correcting the load by comparing with the first
lane of the blot [19]. Thus, in order for the blots to be comparable, we
used an “internal control” of pooled samples loaded in duplicate in all
the blots. Original Western blots of proteins shown in the “Results”
section are presented in Supplementary Fig. 1.2.7. Immunohistochemistry and quantification of immunoreactivity
Formalin-fixed and paraffin-embedded tumor sections were
deparaffinized, rehydrated and stained using the Vectastain Elite
ABC system (Vector Laboratories Inc.). Heat-induced antigen retrieval
was performed using EDTA (for CD3 detection) or citrate buffer (for
CD8 and CD68 detection). For staining of immune cells, anti-CD3
(Abcam), anti-CD8 (Millipore) and anti-CD68 (Abcam) antibodies
were used at a 1:100 dilution.
For quantification of CD3 and CD8 immunostaining, 10 photo-
graphs per tumor at ×400 magnification were taken, and CD-3 and
CD8-positive cells were manually counted. The total number of cells
was quantified by Image J software, and results were expressed as the
percentage of positive cells with respect to the total number of cells in
the sample. For CD68, due to the difficulty to define individual positive
cells, a semiquantitative score system was used by two independent
investigators, classifying the staining as low, medium or high.2.8. Circulating levels of cytokines
Determination of plasma levels of 27 cytokines was performed
with the LuminexMAP technology (Rat Cytokine/ChemokineMagnet-
ic Bead Panel; Milliplex MAP Kit, Millipore) by immunoassay on the
surface of fluorescent-coated magnetic beads following manufactur-
er's instructions. Cytokines analyzed were: GCSF, GMCSF (=CSF2),
leptin, EGF, VEGF, IL1α, IL1β, IL2, IL4, IL5, IL6, IL10, IL12 p70, IL13,
IL17α, IL18, IFNγ, MCP1 (=Ccl2), MIP1α (=Ccl3), RANTES (=Ccl5),
eotaxin (=Ccl11), GRO-KC(=Cxcl1), MIP2 (=Cxcl2), LIX (=Cxcl5),
IP10 (=Cxcl10), fractalkine (=Cx3cl1) and TNFα. Samples were run
in duplicate.
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Plasma levels of 17-β-estradiol and progesteronewere determined
using Estradiol Concentration ELISA Kit and Progesterone Concentra-
tion ELISA Kit according to the manufacturer's directions (GenWay
Biotech, Inc.). Plasma prolactin levels were measured by radioimmu-
noassay using 125I-prolactin (NEN) as the tracer, rat prolactin (rat PRL-
RP-3) as the standard and an antibody rose against rat prolactin (anti-
rPRL-S-9) (Dr. AF Parlow, NIDDK National Hormone and Peptide
Program, CA, USA).
2.10. Metabolic parameters
Nonfasting plasma glucose and insulin levels were obtained at the
end of the assay from animals fed ad libitum as an appropriate and
acceptablemethod based on rodent habits, the stress caused by fasting
and the interference with other parameters [20]. Plasma levels of
glucose were determined using an automated clinical analyzer in the
Biochemistry and Molecular Genetics, Biomedical Diagnostic Center
(CDB), Hospital Clínic. Insulin levels were determined with an insulin
enzyme-linked immunosorbent assay kit from Millipore.
2.11. Statistical analysis
Statistical analyses for histopathological, clinical and molecular
analyses other than microarrays were performed using SPSS software
17.0.Weused parametric or no-parametric statistics dependingon the
distribution of each variable studied, determined by the Kolmogorov–
Smirnov test, and the equality of variances, determined by Levene's
test. Body weight throughout the assay was analyzed using nonlinear
mixed models. Parametric quantitative data were analyzed with
ANOVA followed by Tukey's test and depicted as mean+S.E.M.
Nonparametric quantitative data were analyzed with Mann–
Whitney U test and depicted as median, and mean+S.E.M. is
presented in Supplementary Fig. 2. The χ2 test was used for the
qualitative data. The level of significance was established at Pb.05.
3. Results
3.1. High-fat diets differentially influence tumor malignant phenotype
and tumor growth
Diagnosis of mammary lesions revealed a high percentage of
malignant tumors among all the neoplasias collected (Fig. 2a). Thus,
the percentages of adenocarcinomas in relation to all mammary
tumors (benign and malignant) were: control LF 88.5% (46/52), HCO
84.8% (100/118), LF-HCO 79.8% (87/109), HOO 80.6% (58/72) and LF-
HOO 81.2% (82/101) (Supplementary Table 2).
In order to analyze the tumor aggressiveness, we studied the
differentiation pattern, nuclear pleomorphism and mitotic activity
index of adenocarcinomas. Applying all these parameters, we scored
the modified Scarff–Bloom–Richardson overall grade adapted to rat
mammary carcinomas [15]. Groups of animals fed with high-corn-oil
diet presented the most aggressive tumors, with significant differ-
ences in comparison to control and LF-HOO groups (Fig. 2b). Thus,
while more than 57% of the carcinomas from control showed low
aggressive grade (scores 3–5), fewer tumors in the high-corn-oil-fed
groups exhibited such grade (23% in HCO and 20.1% in LF-HCO),
whereas groups fed the EVOOdiet showed intermediate values (36.5%
inHOO and 41.7% in LF-HOO). On the contrary, the percentage of high-
grade aggressive tumors (scores 9–11) in groups fed the corn-oil-
enriched diet was 33% (HCO) and 39% (LF-HCO), in contrast to the
12.8% in the control group, and also the intermediate percentages of
HOO (21.2%) and LF-HOO (24%). Moreover, tumors from HCO diet
groups showed the highest stromal reaction (24.7% tumors from HCOgroup and 23.5% from LF-HCO showed intense reaction) and tumor
necrosis (in 10.6% of those from LF-HCO was extensive). Tumors from
LF-HCO also displayed the highest mitotic index (Fig. 2c).
The results of carcinogenesis parameters are detailed in Table 1.
Latency timewas shorter in high-corn-oil groups, althoughdifferences
did not reach statistical significance. Tumor incidence was maximum
(100%) in both HCO diet groups, significantly higher than control and
HOO. Tumor yield was higher in the corn-oil-enriched diet groups and
LF-HOO versus the control. HCO, with the largest number of tumors,
was also statistically different to HOO. Finally, total tumor volumewas
higher in all high-fat diet groups, especially in LF-HCO. This
quantitative parameter cannot be statistically analyzed since there is
one single value per group.
3.2. High-fat diets differentially modify the gene expression profile of the
experimental tumors
In order to find genes modulated by dietary lipids, we compared
gene expression profiles of tumors from high-fat diet groups with
those from control group. Lists of differentially expressed sequences
were further compared to identify genes modulated in common (co-
modulated by effect of the high-fat diets) or unique to each specific
group. Venn diagram in Fig. 3a depicts the number of overlapping and
specific genes. In general, there were a low number of common genes.
LF-HCO was the group with the largest number of specific genes.
Analyses of biological significance (functional clustering) of all the
genes found as differentially expressed in each group are shown in
Supplementary Table 3 (GO level 3). Some functional categories were
significantly overrepresented in the clusters of down-modulated genes
in several groups: metabolism, response to stimuli or proliferation and
cell cycle. Moreover, immune system categories were specifically
overrepresented among the down-modulated genes in LF-HCO group.
Functional analysiswasalso performeddividing the clusters of genes
in commonlymodulated and specific for each group. Only genes specific
for LF-HCOandHOOgroups showed significantly enriched categories. In
particular, the genes down-modulated in LF-HCO group were mainly
related to the immunesystem, response to stress andapoptosis (Fig. 3b–
c), whereas the up-modulated genes had a role in metabolism (Fig. 3d–
e). Metabolism, cell homeostasis and proliferation were overrepresent-
ed in the up-modulated genes in HOO group (Fig. 3f–g).
3.3. Validation of gene expression profiles and protein expression analyses
We selected for real-time PCR validation genes regulated in
common (Scd, Fabp3 and Notch4) or specific for each condition and
related to overrepresented functions. Gene expression results were
similar by arrays and real-time PCR when we compared the same six
samples in each group (Supplementary Fig. 3). When real-time PCR
analyseswere extended to 17–22 samples per group, a high variability
among tumors was observed.
Extended analysis is detailed in Fig. 4. In relation to the common
genes, Scd was down-modulated in high-fat diet groups, significantly
in EVOO groups, while Fabp3 and Notch4 were significantly up-
modulated in HCO and EVOO groups. Another metabolism gene,
phosphofructokinase (Pfkl), was up-modulated in LF-HCO and HOO
groups. Expression of genes related to immune system showed great
variability with few significant differences between groups. The
apoptosis-related gene Sema3a was significantly up-modulated in
HOO group. Regarding the genes with a role in proliferation and cell
cycle control, we found differences in the expression of Jak2 (up-
modulated in HCO), Smad1 (down-modulated in high-EVOO diet
groups) and Cdkn2b (up-modulated in LF-HOO), while a not
significant decrease in Stat5a levelswas also observed in EVOOgroups.
Inorder to get insight into theoverrepresented functions, expression
of metabolism and proliferation/apoptosis proteins was analyzed by
Fig. 2. Effects of high-fat diets on the histopathological features of DMBA-induced mammary adenocarcinomas. (a) Representative images of adenocarcinomas from the different
experimental groups (200× magnification). (b) Distribution of mammary adenocarcinomas of each group according to the modified Scarff–Bloom–Richardson index, which includes
differentiation pattern, nuclear pleomorphism and mitotic index (solid line: Pb.05, dashed line: Pb.1, χ2 test). (c) Stromal reaction (− absent, + mild, ++ intense, +++ truly
desmoplastic), necrosis and number of mitosis in 10 high-power fields (400× magnification); solid line: Pb.05, nonparametric Mann–Whitney U test. n=46 (LF), 100 (HCO), 87 (LF-
HCO), 58 (HOO) and 82 (LF-HOO).
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enzyme phosphofruktokinase (PFKL) was performed, and the analysis
was extended to other proteins whose mRNA was found in the
microarrays analysis as modulated by the high-fat diets: Glut1 (Slc2a1)
and Aldolase A (AldoA). Results showed an increase of Glut1 and PFKL
levels in tumors from HOO diet groups compared with those from HCO
diet groups, while no differences in AldoA were found (Fig. 5a).
Notch4, Sema3a, Stat5A/B and Smad1 as well as Caspase 3 and
PCNA were also investigated. No differences in Notch4 and PCNA
were observed (results not shown). The 90-kDa full-length isoform
of Sema3awas barely detected, but the 65-kDa cleaved fragmentwas
decreased, in tumors from EVOO groups. No differences were
observed in the total levels of Smad1/5/9 and StatA/B, but the
activated form of Smad (phopho-Smad 1/5/9) was increased in HCO
versus HOO. On the other hand, total Caspase 3 (Casp3) and its
activated 17-kDa cleaved formwere significantly increased in the LF-
HOO group (Fig. 5b).Table 1
Carcinogenesis parameters
LF HCO
Latency time (days, median) 97 71.5
Incidence (% of tumor-bearing animals) 80 (16/20)a 100 (20/20
Tumor yield (total number of tumors) 46a 100b
Total tumor volume (cm3) 69.3 105.0
Values within a row with different superscript letters are significantly different by Mann–Wh3.4. High-fat diets differentially modulate tumor infiltration of cytotoxic
lymphocytes and immunosuppressive mechanisms
Since no clear trend was observed in the expression of immune
system genes, to further investigate the role of immunological
mechanisms on the effects of the high-fat diets in this experimental
model, we first evaluated tumor infiltration of leukocytes (Fig. 6a).
Infiltration of T lymphocytes (CD3-positive cells) was found to be
similar between the different experimental groups. However, in-
creased cytotoxic T lymphocytes (CD8-positive cells) infiltrate was
observed in the LF-HOO group compared to the LF group. On the other
hand, tumor-associated macrophages (CD68-positive cells) infiltra-
tionwas not influenced by the high-fat diets. Since thesemacrophages
and other populations such as myeloid-derived suppressor cells can
suppress T cell proliferation and activity through production of
arginase (Arg1), inducible nitric oxide synthase (Nos2) and trans-
forming growth factorβ 1 (Tgfβ1), gene expression of thesemoleculesLF-HCO HOO LF-HOO
68 89 89
)b 100 (20/20)b 75 (15/20)a 85 (17/20)ab
87bc 58ac 82bc
188.2 121.9 100.6
itney U test (Pb.05).
Fig. 3. Effects of high-fat diets on gene expression profiles. (a): Number of sequences differentially expressed (Benjamini andHochberg false discovery ratemethod) in adenocarcinomas
(n=6/group) from animals fed the high-fat diets compared to control. Sequences differentially expressed were then compared between high-fat diet groups. Venn diagram depicts the
number of specific and overlapping genes. Blue numbers indicate down-regulated genes, and red numbers indicate up-regulated genes. Italic numbers in parentheses indicate not
annotated sequences (unknown genes). Numbers inside boxes highlight the lists of geneswhere overrepresented functional categories have been found. (b, d, f) Pie charts represent GO
term for biological functions in genes down-regulated in LF-HCO (b), up-regulated in LF-HCO (d) and up-regulated in HOO (f) through PANTHER Classification System. Bold underlined
terms indicate significantly overrepresented functions (Fisher's Exact Test). (c, e, g) GO term enrichment for biological functions in genes down-regulated in LF-HCO (c), up-regulated in
LF-HCO (e) and up-regulated in HOO (g) through FatiGO-Babelomics software (Fisher's exact test).
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mental groups. No differences were found in Nos2. The LF-HOO group
showed lower expression of Arg1compared to both HCO groups and
lower expression of Tgfβ1 compared to all other groups (Fig. 6b).
3.5. Dietary lipids influence circulating levels of inflammatory cytokines
Inflammation is a well-known player on the cancer process; thus,
circulating levels of different inflammation-related cytokines were
evaluated by immunoassay. We first carried out a screening in a panel
of 27 analytes in 6 samples per group from which we selected 7
cytokines for further analyses (MCP1=Ccl2, IL18, GRO-KC=Cxcl1,
VEGF, fraktalkine=Cx3cl1, IL1α and leptin; n=17–19 per group).
Results are shown in Fig. 6c. IL1α plasma levels were higher in the LF-
HCO group comparedwith the other high-fat diet groups. Leptin levels
were increased in all the high-fat diet groups in comparison to the
low-fat control and especially in HCO which also had higher levels
than the LF-HOO group. No statistically significant differences were
found in the other cytokines.
3.6. Dietary lipids effects in other systemic factors
Body weight throughout the study, as well as the body weight
change compared to control, was increased in the rats fed with the
HCO diet from weaning but not if dietary intervention started afterFig. 4. Real-time PCR analysis of genes found in the microarrays as modulated by the high-fat
groups (n=17–22/group). Solid lines connecting groups indicate statistically significant diff
Whitney U test.induction (group LF-HCO). Body mass index was also higher in the
HCO group at the end of the assay (Supplementary Fig. 4). The HOO
diet did not change body weight or mass.
In addition, there were no significant differences between groups
in the metabolic parameters plasma glucose or insulin (Supplemen-
tary Fig. 5). There were also no significant differences in the plasma
levels of the hormones estradiol, progesterone or prolactin (Supple-
mentary Fig. 6).
4. Discussion
In this work, we have observed a different influence of high-fat
diets, depending on the type of fat and timing of dietary intervention,
on anatomopathological and clinical characteristics of experimental
mammary tumors. The diet rich in n-6 PUFA, especially when
administered after puberty onwards, clearly stimulated mammary
carcinogenesis and promoted tumors to a high degree of morpholog-
ical malignancy. The diet rich in EVOO oil exerted a weaker influence,
and tumors developed were more similar to those from low-fat
controls. Gene expression profiles of tumors and validation analysis
also indicated different effects of the high-fat diets, likely being one of
the molecular mechanisms of their influence on mammary carcino-
genesis and suggesting a differential influence of these diets on basic
cellular processes: metabolism, immune system function and prolif-
eration/apoptosis pathways.diets. Data represent relative gene expression (median) in the different experimental
erences (Pb.05); dashed lines indicate differences close to significance (Pb.1), Mann–
Fig. 5. Effects of high-fat diets on the expression of proteins related with metabolism and with proliferation/apoptosis pathways. (a) Representative Western blots and relative protein
levels of glycolytic enzymes (PFKL, AldoA) and the glucose transporter Glut1 in the different experimental groups. (b) Representative Western blots and relative levels of proteins
related to proliferation and apoptosis pathways. Bars represent medians. Solid lines connecting groups indicate statistically significant differences (Pb.05); dashed lines indicate
differences close to significance (Pb.1), Mann–Whitney U test, n=8–20/group. ic refers to an internal control of pooled samples.
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the DMBA-induced animals showed the predominance of malignant
adenocarcinomas and confirmed their similarity with human tumors
[15]. Benign and malignant tumors arise from different epithelial
structures, and benign lesions are highly influenced by hormones such
as prolactin [21]. Although these high-fat diets have shown to
influence the puberty onset [14], which would affect the number of
differentiated structures at the moment of induction, there were no
significant differences between groups in the percentage of the
malignant tumors in relation to all mammary tumors, as well as no
differences in hormone levels by effect of high-fat diets.
We characterized the tumormalignant phenotype determining the
tumor growth and the degree of morphological aggressiveness by
applying the modified Scarff–Bloom–Richardson gradingmethod that
we previously described [15]. Results revealed that adenocarcinomas
from animals fed with the high-corn-oil diet, especially from LF-HCO
group, displayed morphologic characteristics of high malignancy, i.e.,
high pattern and nuclear grade, mitotic activity, stromal reaction and
necrotic areas, as well the overall histopathologic grade. Likewise, the
study of clinical parameters of the carcinogenesis showed a clear
stimulatory effect of the high-corn-oil diet since HCO and LF-HCO
groups had the earliest onset of tumor appearance and the highest
incidence and total malignant mammary tumors. However, the high-
EVOO diet exerted a weaker stimulating effect on mammary
carcinogenesis since tumors from animals fed such diet showed
intermediate values between control and the high-corn-oil groups in
the anatomopathological and clinical parameters.
The stimulating effect that n-6 PUFA-enriched diet exerted on
mammary carcinogenesis was stronger during the promotion phase,
given that tumors showed characteristics of higher malignancy when
the dietary intervention started after induction (group LF-HCO). Thedifferential effect that this diet may exert depending on the timing of
dietary exposure could be related to several factors. On the one hand,
the administration of this diet from weaning advanced the puberty
onset [14], thus modifying the window of susceptibility of the
mammary gland [21] and therefore the progression of the carcino-
genesis. Puberty is a particularly sensitive life stage in which dietary
factors can have a great influence [14,22]. On the other hand,we found
an effect of this diet on the initiation of carcinogenesis through the
modulation of detoxification enzymes [23,24]. In addition, the HCO
diet has a clear promoter effect, already observed in previous works
[8,13,14,25,26] and in other experimental models [27–29]. The
combination of all these effects would produce a greater initiation of
cancer in the HCO group than in the LF-HCO, but of slower progression
(more tumors but with a slight increase in the latency time and of
smaller volume, number of mitosis and necrosis).
The effects of the high-fat diets through the caloric density should
also be taken into consideration. Animals fed with the HCO diet from
weaning did gain significant body weight and mass in the long term,
which is in accordancewith the highest leptin levels in the HCO group.
Also interesting are the consequences that such diet may have to the
metabolic conditions associated to obesity. In this regard, there were
no significant differences in plasma glucose or insulin levels between
groups despite the increased body weight in HCO group. Several
known risk factors (such as early sexual maturation or obesity) can be
underlying mechanisms of the high-fat diet effects of tumorigenesis.
Nevertheless, the HCO diet had a clear promoting effect on
carcinogenesis in normal-weight animals (group LF-HCO).
On the other hand, few studies have investigated the effects of
EVOO on mammary carcinogenesis. We have previously observed
from aweak protective [3,13,25] to a weak promoting [14,26] effect of
the high-EVOO diet on experimental breast cancer. In any case, all the
Fig. 6. Effects of high-fat diets on immune system function. (a) Representative images (magnification ×400) and quantification of CD3, CD8 and CD68 immunostaining in the different
experimental groups, n=18–20/group. (b) Gene expression of the immunosuppressive mediators arginase 1 (Arg1), nitric oxide synthase 2 (Nos2) and transforming growth factor β 1
(Tgfβ1), n=16–31/group. (c) Circulating levels of inflammation-related cytokines in plasma, n=17–19/group. Bars represent medians, except for CD68. For CCL2, IL18, CXCL1, VEGF
and CX3CL1, dots represent medians and whiskers 25th–75th percentiles. Solid lines connecting groups indicate statistically significant differences (Pb.05), Mann–Whitney U test.
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this diet, despite being influenced by a high intake of total fat, showed
clinical and histopathological characteristics of low aggressiveness,
similar to those from control group. Considering the unspecific
stimulating effect on carcinogenesis through caloric density [30] and
that both experimental high-fat diets were isocaloric, the results
suggest a beneficial effect of the EVOO that partially counteracts the
deleterious effect of an excessive intake of fat. Differences observed
among the assays can be related to the different timing of the dietary
intervention, aswell as to distinct varieties of oil used, since it has been
reported that the influence of olive oil on carcinogenesis depends on
the proportions of oleic acid and minor bioactive components [31].
Several molecular mechanisms have been proposed in relation to
the effects of dietary fat on carcinogenesis. There is evidence that
dietary fatty acids (FA) modulate biological functions through the
regulation of gene expression [9,32]. Hence, we analyzed theinfluence of these high-fat diets on the gene expression profile of
mammary adenocarcinomas. Although the number of differentially
expressed genes was low, probably due to the intrinsic high
variability among tumors, transcriptomic analysis showed different
effects of corn oil and EVOO. Biological significance analysis and
functional clustering of differentially expressed genes revealed
different enriched categories depending on the type of diet admin-
istered. The high-n-6-PUFA diet down-modulated genes related to
cell death and immune response, whereas the high-EVOO diet up-
modulated geneswith a role in cell death and proliferation.Moreover,
when we divided clusters of genes in commonly modulated
(influenced by both kinds of high-fat diets) or specific for each
group, among the genes only down-modulated in LF-HCO, apoptosis
and immune system were also significantly overrepresented
categories. Metabolic processes were also enriched categories by
both high-fat diets.
226 R. Escrich et al. / Journal of Nutritional Biochemistry 64 (2019) 218–227Further expression analyses by real-time PCR have also suggested
metabolic adaptation to the increased intake of lipids in all high-fat
diets groups, up-regulating the expression of the fatty acid binding
protein Fabp3 and down-regulating that of the desaturase enzyme
Scd, especially in the EVOO groups. Extensive evidence has been
published regarding metabolic dysfunction of cancer cells, but there
are little data about how a high intake of FA probably determines the
metabolic adaptation of tumor cells. Transformed cells have a highly
increased need for FA, and it has beenmostly considered that themain
source of FA in tumor cells was de novo synthesis [33]. However, our
expression results point out the importance of the extracellular source
of lipids. Besides the adaptation to the high amount of unsaturated FA,
our results indicate other metabolic modifications that depend on the
type of FA administered. Expression and Western blot analyses
suggested enhanced glycolytic pathways by effect of the high-EVOO
diet in comparison with the high-corn-oil diet, rising PFKL levels (a
key point control of glycolytic pathway) and the glucose transporter
Glut1. Nevertheless, recently, the intratumoral compartmentalization
of metabolic features and the distinct relevance if enzymes are
expressed by cancer epithelial cells or cancer-associated fibroblasts
[34] have been pointed out. Further studies are needed to elucidate the
significance of the effects of high-fat diets in the context of
microenvironment and dynamic interplay among cell types.
On the other hand, several genes related to proliferation/apoptosis
pathways were detected as differentially modulated by the high-fat
diets, although the variability among tumors resulted in subtle
differences, which were later analyzed at the protein level. Sema3a
protein has been related to apoptosis, migration and regulation of the
tumor microenvironment including the immune cells [35]. While the
full-length mRNA was up-regulated in the HOO group, a proteolytic
65-kDa isoform was significantly decreased. Although disparate data
have been published, this isoform was originally reported as a
fragment with reduced functional activity [36]. Thus, the interpreta-
tion of the increased mRNA but decreased cleaved protein by effect of
EVOO is unclear but suggests modifications in apoptosis and/or
immunosurveillance. In relation to proliferation genes, different
trends have also been observed in expression analysis in concordance
with the clinical and morphological features of tumors. Smad1 mRNA
(a promoter of proliferation andmigration [37])was decreased in both
high-olive-oil groups. While little differences were observed in
Smad1/5/9 protein levels, the active protein (phosphoSMAD1/5/9)
was significantly increased in HCO compared to HOO, which was in
accordancewith the higher degree of malignancy of tumors fromHCO
group. Some differences were also observed in the total levels of
Stat5A/B proteins, but they did not reach significance. We further
determined key proteins in apoptosis (Caspase 3 and its activated
cleaved form), finding increased levels of activated Caspase 3 in
tumors from LF-HOOwhich suggested an increase in apoptosis in such
tumors.
In relation to immune system, it has been reported that the
expression of immune genes reflects leukocytes infiltration in tumor
tissue [38]. However, although microarrays indicated down-
modulation of Il18 and Il2Rg in LF-HCO group, extended real-time
PCR analysis did not confirm such regulation. Since it is likely that
subtle modifications in leukocyte infiltration may not be detected in
whole tumor extracts, immunohistochemical analyses were conduct-
ed. Thus, we observed an increase in the infiltration of cytotoxic T
lymphocytes (CD8) in tumors from LF-HOO group. Other authors have
also suggested an effect of an EVOO diet on production of CD8
lymphocytes and their infiltration into the colon mucosa of colon-
tumor-bearing rats [39], and immunomodulatory effects on B
lymphocytes [40] and natural killer cells [41]. In addition, we also
evaluated tumor-infiltratingmacrophages, a cell population that plays
a key role in the generation and maintenance of an immunosuppres-
sivemicroenvironmentwithin the tumor. The groups fed the HCO dietexhibit increased staining for CD68, the marker of macrophages, but
differences between groups were not statistically significant. Never-
theless, other studied markers [42] did suggest differences in the
immunosuppressive context of tumors by effect of the dietary
intervention, resulting in higher levels of arginase in HCO groups,
while in the LF-HOO group, Tgfβ1 was down-modulated. Moreover,
plasma levels of the proinflammatory and protumorigenic [43]
cytokine IL-1α and those of Leptin were increased in HCO group in
comparison with animals fed the high-EVOO diet. Taken together,
these results suggest that there is a modulation of the immune system
by dietary intervention that would be one of the mechanisms on the
differential effects of these high-fat diets on the tumor progression.
Finally, results ofmicroarraysprofilingandvalidationby real-timePCR
highlighted the molecular heterogeneity among tumors and within a
single tumor. Beyond the limitations of each technique, both methodol-
ogies showed concordant results in the same samples, while intertumor
variability was manifested when analyses were extended to a higher
number of samples. Thus, each tumor has a unique and also heteroge-
neous molecular context with its single combination of genomic and
epigenomic features, where environmental factors may exert subtle but
relevant influence. Taking all the molecular results together and
considering the effects of these diets on the anatomopathological and
clinical characteristics of the mammary tumors, a scenario is plausible in
which tumors from animals fed the high-EVOO diet showmodulation of
pathways conducting to Casp3mediated apoptosis, perhaps enhanced by
Sema3aactivity (which couldalsoparticipate in immunosurveillance).On
the other hand, a high intake of corn oil would induce more active
proliferation pathways, e.g., increasing the active form of Smad1, and a
more inflammatory phenotype.
In conclusion, this work reports several effects of high-fat diets on
experimental breast carcinogenesis depending on the type and time of
dietary intervention, showing a clear stimulating influence of corn-oil-
enriched diet which is manifested on the morphological and clinical
characteristics of tumors. The high-EVOO diet, despite having the
unspecific promoting effect that all high-fat diets exert, seemed to
have some beneficial influence eliciting a progression of tumors more
similar to that of the controls. Different and complex molecular
mechanismswould drive such effects, includingmodifications in gene
expression profiles and changes in metabolic pathways, alteration in
immunosurveillance and modifications in proliferation/apoptosis
balance. Thus, these results point out the relevance that dietetic
habits from childhood may have on the susceptibility to malignant
transformation and the progression of the disease.
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